Description

Cancer patients are afraid of such adverse reactions as nausea and emesis caused by chemotherapy. Severe nausea and vomiting will make future chemotherapy a daunting experience for patients. They may even feel unwilling or give up further chemotherapy, which will make chemotherapy difficult to continue. 5-HT3 receptor antagonist, an antiemetic, acts by competitively preventing 5-HT from combining with 5-HT3 receptor. Ever since GSK developed the first generation of selective 5-HT3 receptor antagonist ondansetron under the trade name of Zofran, a bunch of derivatives have come out, including tropisetron made by Novartis under the trade name of Navoban.

View Full Report at: http://www.marketresearchreports.biz/analysis/289097

Tropisetron, developed by Novartis, entered the market in the Netherlands in 1992 and then the Chinese market in the late 1990s. Tropisetron got administrative protection authorized by the Chinese government in Mar. 1994 after its original developer Sandoz submitted application. But it is now a generic drug for its patent expired on Sep. 22, 2001. Tropisetron develops fast into the absolute leader antiemetics after entering China with annual sales rising from CNY 41 million in 2005 to CNY 600 million in 2014 and CAGR reaching up to 34.7% during the period of 2005-2014. Currently, the tropisetron market in China is basically occupied by generic drugs which come from the following companies: Southwest Pharamceutical Co., Ltd, Wellso Pharmaceutical Co., Ltd, ReYoung Pharmaceutical Co., Ltd, Shandong Luoxin Pharmacy Stock Co., Ltd and Qilu Pharmaceutical Co., Ltd

Tropisetron has big profit margins and is easy to be applied to clinics. Since there are hundreds of thousands of cancer patients undergoing chemoradiotherapy, tropisetron enjoys a promising market in China.

Download Detail Report With Complete TOC at: http://www.marketresearchreports.biz/sample/sample/289097

Readers can get at least the following information through this report:

market share of manufacturers of tropisetron in Chinese market
price of tropisetron in Chinese market
major manufacturers of tropisetron in China
share of different dosage forms of tropisetron in Chinese market
market outlook of tropisetron in China

The author suggests the following groups of people purchase this report:

pharmaceutical enterprises
investors/ research institutions interested in Chinese medicine market
any interest in Chinese medicine market, please contact CRI for customized survey service

Table of Content

1 Related Concepts of Tropisetron
1.1 Indication
1.2 Sales Status in Global Market

2 Market Profile of Tropisetron in China
2.1 Patent and Approval Status of Tropisetron in China
2.2 Major Manufacturers
2.3 Market Size

3 Survey on Sales Status of Tropisetron in China, 2010-2014
3.1 Sales Value
3.1.1 Overall Sales Value
3.1.2 Sales Value by Regions
3.2 Sales Volume
3.2.1 Overall Sales Volume
3.2.2 Sales Volume by Regions


Browse all latest Articles of Market Research Reports
at:http://www.marketresearchreports.biz/articles


About us

MarketResearchReports.biz is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save time and money for our clients.
We are a one stop solution for all your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting services. We serve all sizes and types
of companies spanning across various industries.


Browse Our Press Releases by Prnewswire:
http://www.prnewswire.com/news/marketresearchreports.biz


Browse More PressRelease:
http://www.prweb.com/search.aspx?search-releases=marketresearchreports.biz



Contact
Mr. Nachiket
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA: Canada Toll Free: 866-997-4948
Website: http://www.marketresearchreports.biz/
E: [email protected]